Logo image of RHE

REGIONAL HEALTH PROPERTIES (RHE) Stock Fundamental Analysis

NYSEARCA:RHE - NYSE Arca - US75903M3097 - Common Stock - Currency: USD

2.7741  +0.09 (+3.51%)

Fundamental Rating

1

RHE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. RHE has a bad profitability rating. Also its financial health evaluation is rather negative. RHE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RHE had negative earnings in the past year.
RHE had a positive operating cash flow in the past year.
RHE had negative earnings in 4 of the past 5 years.
Of the past 5 years RHE 4 years had a positive operating cash flow.
RHE Yearly Net Income VS EBIT VS OCF VS FCFRHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

RHE's Return On Assets of -4.81% is on the low side compared to the rest of the industry. RHE is outperformed by 62.96% of its industry peers.
Industry RankSector Rank
ROA -4.81%
ROE N/A
ROIC N/A
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
RHE Yearly ROA, ROE, ROICRHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K 15K 20K

1.3 Margins

The Gross Margin of RHE (49.69%) is better than 76.85% of its industry peers.
The Profit Margin and Operating Margin are not available for RHE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RHE Yearly Profit, Operating, Gross MarginsRHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

More info and screens

0

2. Health

2.1 Basic Checks

RHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RHE has more shares outstanding
RHE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RHE is higher compared to a year ago.
RHE Yearly Shares OutstandingRHE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
RHE Yearly Total Debt VS Total AssetsRHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

RHE has an Altman-Z score of -1.80. This is a bad value and indicates that RHE is not financially healthy and even has some risk of bankruptcy.
RHE's Altman-Z score of -1.80 is on the low side compared to the rest of the industry. RHE is outperformed by 82.41% of its industry peers.
The Debt to FCF ratio of RHE is 60.13, which is on the high side as it means it would take RHE, 60.13 years of fcf income to pay off all of its debts.
RHE's Debt to FCF ratio of 60.13 is in line compared to the rest of the industry. RHE outperforms 51.85% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 60.13
Altman-Z -1.8
ROIC/WACCN/A
WACC5.19%
RHE Yearly LT Debt VS Equity VS FCFRHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

RHE has a Current Ratio of 0.29. This is a bad value and indicates that RHE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.29, RHE is doing worse than 93.52% of the companies in the same industry.
RHE has a Quick Ratio of 0.29. This is a bad value and indicates that RHE is not financially healthy enough and could expect problems in meeting its short term obligations.
RHE's Quick ratio of 0.29 is on the low side compared to the rest of the industry. RHE is outperformed by 93.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
RHE Yearly Current Assets VS Current LiabilitesRHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

RHE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -108.34%.
RHE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.56%.
The Revenue has been decreasing by -4.88% on average over the past years.
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RHE Yearly Revenue VS EstimatesRHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

RHE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RHE Price Earnings VS Forward Price EarningsRHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

RHE's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RHE indicates a rather cheap valuation: RHE is cheaper than 95.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.77
EV/EBITDA 28.41
RHE Per share dataRHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RHE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REGIONAL HEALTH PROPERTIES

NYSEARCA:RHE (2/3/2025, 8:04:01 PM)

2.7741

+0.09 (+3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13 2024-11-13
Earnings (Next)03-31 2025-03-31
Inst Owners2.13%
Inst Owner Change-60.32%
Ins Owners14.05%
Ins Owner Change0%
Market Cap5.22M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.45
Dividend Growth(5Y)90.1%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF 6.77
P/OCF 4.2
P/B N/A
P/tB N/A
EV/EBITDA 28.41
EPS(TTM)-1.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY14.76%
OCF(TTM)0.66
OCFY23.81%
SpS9.15
BVpS-1.27
TBVpS-3.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.69%
FCFM 4.48%
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 60.13
Debt/EBITDA 25.78
Cap/Depr 23.41%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 69.15%
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -1.8
F-Score4
WACC5.19%
ROIC/WACCN/A
Cap/Depr(3y)19.64%
Cap/Depr(5y)15.23%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.86%
FCF growth 3Y48.26%
FCF growth 5Y22.22%
OCF growth 1Y189.42%
OCF growth 3Y42.05%
OCF growth 5Y22.46%